Project Grant S10OD038226
- The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP), under the Research Infrastructure Programs (CFDA 93.351), awarded a $1,990,349 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to build and support a High-Performance Computing (HPC) cluster for computational pathology research. The project aims to address the growing need for enhanced data processing and analysis capabilities to support...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $161,169 Project Grant by the Office of the Director at the National Institutes of Health under the Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art metabolic/gas exchange system compatible with magnetic resonance imaging (MRI). This specialized equipment will enable a wide range of breath-by-breath gas exchange and pulmonary function measurements as well as...
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $578,070 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a high-resolution portable photon counting computed tomography (CT) scanner. The equipment will be shared by researchers across the Departments of Anesthesia, Radiology, Neurosurgery, and Surgery at MGH and Boston Children's Hospital. The new CT...
- This $2,000,000 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the upgrade and maintenance of a 14T/600 MHz high-field nuclear magnetic resonance (NMR) spectrometer and microimager at Massachusetts General Hospital (MGH). This cutting-edge biomedical research instrument has made significant contributions to diverse fields, including contrast agent development, tissue pathology, and the study of conditions like...
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,835,840 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to purchase a clinical-grade NVISION POLARIS C13 Polarizer. This instrument enables hyperpolarization of C13 substrates, providing over a 10,000-fold increase in MRI signal for metabolic imaging. The award will allow Massachusetts General Hospital to be the only...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,485,000 Project Grant award from the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award period runs from September 1, 2025 to August 31, 2028. The grant supports research focused on the discovery and characterization of programmable biological systems, particularly new RNA-guided functions found in...
- The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will provide $600,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a next-generation 3 Tesla human MRI scanner for mental health research. The new MRI system will replace an obsolete 16-year-old scanner and integrate with MGH's existing PET-MRI facility at the Athinoula A. Martinos Center for Biomedical Imaging. The...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) provides $872,734 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a Leica Stellaris 8 Falcon confocal microscope. The new microscope will modernize the imaging platform at MGH's Center for Immunology and Inflammatory Diseases (CIID), replacing an aging confocal microscope that is no longer...
- The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (dMRI) technologies. This funding will enable MGH to create novel acquisition methods that can provide significant...
The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $255,500 Project Grant (CFDA 93.351) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a new digital multi-isotope autoradiography system. This advanced imaging equipment will be housed at the Institute for Innovation in Imaging at MGH and will provide highly sensitive, real-time analysis of isotope distribution in tissue samples. The award, with a period of performance from August 1, 2025 to July 31, 2026, will establish the only such instrument in the greater Boston area, significantly strengthening MGH's research capabilities in areas such as positron emission tomography, probe development, and translational research across multiple scientific domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $255.5k | 8/1/25 |